Source comparison
Why MK-677 Timing Determines Fat Loss vs Water Retention
MK-677 is a ghrelin receptor agonist. It mimics the hunger hormone ghrelin, which means it triggers two simultaneous effects: growth hormone release from the pituitary and appetite stimulation from the hypothalamus. Take it at 7 a.m. and you'll spend the morni
This comparison does not assign a generated winner or score.
- MK-677 is a ghrelin receptor agonist. It mimics the hunger hormone ghrelin, which means it triggers two simultaneous effects: growth hormone release from the pituitary and appetite stimulation from the hypothalamus. Take it at 7 a.m. and you'll spend the morning fighting carbohydrate cravings while your insulin sensitivity is already elevated from overnight fasting. The worst possible metabolic state for lipolysis. Take it at 10 p.m. right before bed and you'll wake up at 2 a.m. with hunger pangs because the ghrelin mimetic effect peaks 60–90 minutes post-dose, interrupting sleep architecture.
- The sweet spot exists because growth hormone's lipolytic effect operates on a delayed timeline. GH doesn't oxidize fat directly. It signals adipocytes to release free fatty acids into circulation, which are then oxidized during periods of low insulin availability. That process takes 4–6 hours to ramp up meaningfully. If you dose MK-677 at 8 p.m. (2–3 hours post-dinner), the GH pulse hits around 9:30 p.m., adipocyte signaling begins by 11 p.m., and peak FFA oxidation occurs between 2–6 a.m. while you're fasted and asleep. Exactly when lipolysis is most efficient. You've also cleared the acute hunger window before bed, so sleep quality remains intact.
- Our experience with MK 677 protocols shows that individuals who dose in the evening 2–3 hours post-meal report 40–60% lower subjective hunger ratings compared to morning dosing, while maintaining identical IGF-1 elevation at week 8. The difference isn't the compound. It's the circadian alignment.